PhRMA Selects Medidata Solutions, Inc.’ Extensive Real-world Cost Databases for Clinical Trial Analysis

NEW YORK--(BUSINESS WIRE)--The major trade group for the global pharmaceutical industry, Pharmaceutical Research and Manufacturers of America (PhRMA), and economic consulting firm Analysis Group, Inc. (AG) have selected benchmark industry tools from Medidata Solutions (NASDAQ: MDSO) as the key input for research into the costs of post-approval clinical trials.

Back to news